METHYSERGIDE MALEATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methysergide maleate and what is the scope of patent protection?
Methysergide maleate
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for METHYSERGIDE MALEATE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 643 |
DailyMed Link: | METHYSERGIDE MALEATE at DailyMed |
Medical Subject Heading (MeSH) Categories for METHYSERGIDE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for METHYSERGIDE MALEATE
US Patents and Regulatory Information for METHYSERGIDE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | SANSERT | methysergide maleate | TABLET;ORAL | 012516-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |